Old Web
Bevacizumab Failure in Recurrent Glioblastoma
2010
Bevacizumab is a humanized monoclonal antibody against vascular endothelial growth factor that recently received FDA approval for use in recurrent
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
1
References
0
Citations
NaN
KQI